Methadone, oral
Phase 3
Methadone, oral is one of 10 therapeutic programs targeting Pain, Postoperative. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
9
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
9 competitors in Pain, Postoperative
#DrugCompanyPhaseTrials
1Tylenol
KKenvue Brands
Approved
Dolophine
HHikma Pharmaceuticals LLC
Approved
Decadron
AAspen Global Incorporated
Approved
Advil
KKenvue Brands
Approved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Tegileridine
XXin Chen
Phase 3
Acetominophen
Merck & Co.Phase 3
Liposomal Bupivacaine
TTLC Biopharmaceuticals, Inc.
Phase 2
Methadone, oral
MMayo Clinic
Phase 3
Dexamethasone Palmitate
XXijing Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Methadone, oral. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 3[1]
- Company
- MMayo Clinic